• Return to Headlines

37.8% Return Seen to Date on SmarTrend Esperion Therape Call (ESPR)

By Amy Schwartz

SmarTrend identified an Uptrend for Esperion Therape (NASDAQ:ESPR) on June 21st, 2017 at $38.29. In approximately 3 months, Esperion Therape has returned 37.80% as of today's recent price of $52.77.

Over the past year, Esperion Therape has traded in a range of $9.40 to $57.38 and is now at $52.77, 461% above that low. Over the last five market days, the 200-day moving average (MA) has gone down 5.3% while the 50-day MA has declined 0.6%.

Esperion Therapeutics, Inc. develops and markets medical devices. The Company produces oral and small molecule therapies for the treatment of patients with elevated levels of low-density lipoprotein cholesterol and other cardio metabolic risk factors.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Esperion Therape shares.

Log in and add Esperion Therape (ESPR) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights esperion therape

Ticker(s): ESPR